Autolus Therapeutics plc American Depositary Share (NASDAQ: AUTL) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT AUTOLUS THERAPEUTICS PLC AMERICAN DEPOSITARY SHARE

Autolus Therapeutics plc American Depositary Share (NASDAQ: AUTL)
Listen to this Section


$1.53
-0.1300 ( -7.83% ) 988.9K

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Market Data


Open $1.53
Previous Close $1.66
Volume 988.9K
Market Cap $431.15M
Day Range $1.53 - $1.72
52 Week Range $1.18 - $2.70
Shares Outstanding 266.14M
Change % -7.83%
Net Change ▼ -0.1300
Insider Ownership N/A
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2018
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
8-k 8K-related 44 Nov 12, 2025
10-q Quarterly Reports 96 Nov 12, 2025
8-k 8K-related 35 Aug 12, 2025
10-q Quarterly Reports 132 Aug 12, 2025
8-k 8K-related 13 Jun 27, 2025
8-k 8K-related 183 Jun 02, 2025

Latest News


× Before browsing our site, please accept our cookies policy